ICD-10 F64.2 is officially defined as "Gender identity disorder of childhood." code F64.2 is referenced in 7 tracked payer policy changes from New Mexico Medicaid, Independence Blue Cross, and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code F64.2 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
New Mexico Medicaid now covers gender affirming care (pubertal blockage and hormone therapy) for eligible members ages 12-17 with documented gender dysphoria diagnosis, effective October 13, 2026. Billing requires prior authorization, separate visit coding with diagnosis F64.2, condition code 45 for UB-04 claims, and submission clarification code 99 for pharmacy claims paid with state funds.
Independence Blue Cross updated HCPCS codes L8030 and L8031 and revised ICD-10 diagnosis codes for gender-affirming interventions, effective October 1, 2026. The policy deleted Z87.890 (Personal history of sex reassignment) and added five new Z87.89xx codes for specific types of gender transition history, plus F64.A (Gender identity disorder, in remission). Billing teams must update coding systems to reflect these ICD-10 changes and ensure accurate diagnosis code selection for claims processing.
Independence Blue Cross updated policy 11.09.02s to version 11.09.02t, effective 01/01/2026, replacing HCPCS code S0189 (testosterone pellet implant) with J1073. Additionally, policy statements for fully insured New York members were revised as of 04/29/2026, with an associated attachment requiring medical necessity review. The coverage criteria for gender-affirming interventions remain unchanged; this is primarily a code update with state-specific documentation changes.
Nevada Medicaid now requires prior authorization for specific gender dysphoria surgical procedures when billed with certain diagnosis codes (F64.0, F64.1, F64.2, F64.8, F64.9, or Z87.890). Six specific procedure codes are affected, and modifier KX or condition code 45 is still required for transgender patient claims.
Kansas Medicaid will no longer cover new surgical or hormonal gender affirming care for adults 21 and older starting September 1, 2025. Claims with gender dysphoria diagnosis codes will automatically suspend for manual review to check for grandfathered exceptions.
Independence Blue Cross reissued medical policy 11.09.02t for gender-affirming interventions, which supersedes version 11.09.02r. The policy underwent an annual review on 12/10/2025 and includes a HCPCS code update effective 07/01/2025 for J1954 (puberty-suppressing hormone). The policy establishes medical necessity criteria for coverage of puberty-suppressing hormones, hormone-replacement therapy, and bilateral mastectomy for individuals with gender dysphoria or gender diversity.
Independence Blue Cross reissued policy 11.09.02r (now superseded by 11.09.02t) covering gender-affirming interventions including puberty-suppressing hormones, hormone-replacement therapy, and bilateral mastectomy. The policy was updated on 12/10/2025 per annual review process, with a prior HCPCS code update effective 07/01/2025 for J1954 and related pharmaceutical codes. Billing teams must ensure claims for covered gender-affirming services include proper behavioral health documentation and meet medical necessity criteria outlined in the policy.
Watch F64.2
Get one email when a payer policy names F64.2, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.